SANGAMO THERAPEUTICS, INC.
SGMO · NASDAQ
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, cell therapy, and genome engineering.
Market Data
Price
$0.14
-0.02 (-11.17%)
Market Cap$30M
P/E Ratio—
EPS$—
52W High$0.77
52W Low$0.03
Beta1.56
Data from Finnhub · Updated Aug 24, 2026